Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome?Positive Acute Lymphoblastic Leukemia Ph+ ALL
A Phase II Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies
A Randomized Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors
Study Type: Treatment
Phase: III
NCTID: NCT02582697
Principal Investigator:
Keith August
A Phase III, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing Mezigdomide CC-92480, Bortezomib And Dexamethasone MEZIVd Versus Pomalidomide, Bortezomib And Dexamethasone PVd In Subjects With Relapsed Or Refractory Multiple Myeloma RRMM: SUCCESSOR-1
Program Title: Managed Access Program MAP Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel CTL019; Kymriah�
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO
Study Type: Prevention
Phase: II
NCTID: NCT02679144
Principal Investigator:
Kevin Ginn